OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
Emanuel Raschi, Simone Rossi, Andrea De Giglio, et al.
Drug Safety (2023) Vol. 46, Iss. 9, pp. 819-833
Open Access | Times Cited: 18

Showing 18 citing articles:

Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations
Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1440-1440
Open Access | Times Cited: 22

Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review
Demis N. Lipe, Aiham Qdaisat, Pavitra P. Krishnamani, et al.
Diagnostics (2024) Vol. 14, Iss. 16, pp. 1794-1794
Open Access | Times Cited: 4

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Helena T. Wu, Van Doren Hsu, Shwe Win, et al.
Visualized Cancer Medicine (2025) Vol. 6, pp. 1-1
Open Access

Cardiogenic shock in patients with active onco-hematological malignancies: A multicenter retrospective study
Mickaël Lescroart, H. Kemp, Olivier Imauven, et al.
Journal of Critical Care (2025) Vol. 87, pp. 155028-155028
Closed Access

Advancements in Diagnosis and Treatment of Cardiac Sarcomas: A Comprehensive Review
Xuezhe Wang, Xinchi Luan, Wuliang Yin, et al.
Current Treatment Options in Oncology (2025) Vol. 26, Iss. 2, pp. 103-127
Closed Access

Microbiota-indole-3-propionic acid-heart axis mediates the protection of leflunomide against αPD1-induced cardiotoxicity in mice
R. Stephanie Huang, Zhuo-Yu Shen, Dan Huang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, et al.
ESC Heart Failure (2025)
Open Access

New onset of hypertension associated with immune checkpoint inhibitor therapy in cancer patients
HangYu Watson, Nolan Holley, Tabot Ntoung Nkongho, et al.
Immunotherapy (2025), pp. 1-9
Closed Access

Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials
Martina Bortolot, Francesco Cortiula, Gianpiero Fasola, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102797-102797
Closed Access | Times Cited: 2

Blocking CTLA‐4 promotes pressure overload‐induced heart failure via activating Th17 cells
An‐Qi Shang, Changjiang Yu, Xin Bi, et al.
The FASEB Journal (2024) Vol. 38, Iss. 15
Closed Access | Times Cited: 2

Plasma exchange plus glucocorticoids in the treatment of immune checkpoint inhibitor‐induced myocarditis: A case series and review
Guibao Ke, Peian Chen, Jing Luo, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 12, pp. 1481-1487
Open Access | Times Cited: 4

Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy
Lida Feng, Guixiao Huang, Qifang Lei, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 7
Closed Access | Times Cited: 1

Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy
Bhargav Makwana, Aishwarya Malode, Sumanth Khadke, et al.
Cardiology Clinics (2024) Vol. 43, Iss. 1, pp. 151-167
Closed Access | Times Cited: 1

Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11299-11299
Open Access | Times Cited: 1

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
Roberta Noseda, Francesca Bedussi, Valentina Giunchi, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e009902-e009902
Open Access | Times Cited: 1

Page 1

Scroll to top